Evidence map›Paper›PMID 32476900›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2018

A case report of steroid resistant cardiac sarcoidosis successfully managed with methotrexate.

Olga Grabowska, Magdalena M Martusewicz-Boros, Dorota Piotrowska-Kownacka, Elżbieta Wiatr

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Diagnostic and therapeutic practices of cardiac sarcoidosis in the United States: a nationwide questionnaire based study.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Olga GrabowskaMazovian Center For Treatment of Lung Diseases and Tuberculosis, Otwock, Poland.
Magdalena M Martusewicz-Boros3 Lung Diseases Dept., National TB & Lung Diseases Research Institute, Warsaw, Poland.
Dorota Piotrowska-Kownacka1st Department of Clinical Radiology, Medical University of Warsaw, Warsaw, Poland.
Elżbieta Wiatr3 Lung Diseases Dept., National TB & Lung Diseases Research Institute, Warsaw, Poland.
Medical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Up to one fourth of sarcoidosis patients may have cardiac involvement, what is potentially a life-threatening condition and requires aggressive treatment. Corticosteroids are generally effective in cardiac sarcoidosis, however may have significant short and long term adverse effects. We present a case of a 42-year-old male, who was diagnosed with pulmonary and cardiac sarcoidosis. He was treated initially with corticosteroids and satisfactory improvement was achieved in the lungs but not in the heart. Methotrexate was added as a second line therapy, being beneficial for the heart as well as steroid sparing agent. Cardiac improvement was documented during serial CMR imaging.

Indexed as

cardiac sarcoidosiscorticosteroidsmethotrexatesarcoidosis

Identifiers

PMID32476900
PMCPMC7170091
OpenAlexW3030574186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.